14 results
10-K/A
2022 FY
CADL
Candel Therapeutics Inc
1 May 23
Annual report (amended)
8:01am
executive officers with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executive officers
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
to contribute positively to the collaborative culture among board members, and their knowledge of our business and understanding of the competitive landscape … our executive officers with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executive
10-K
dfg qcdb6r
29 Mar 22
Annual report
8:46am
424B4
g6nbeb
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
rsbw6qz
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.9
qh7ic 2noqc2
16 Jul 21
IPO registration (amended)
6:07am
S-1
EX-10.9
552a16p2epph
25 Jun 21
IPO registration
5:28pm
S-1
fms9ik6 tnit
25 Jun 21
IPO registration
5:28pm
S-1
EX-10.8
eteii3
25 Jun 21
IPO registration
5:28pm
DRS/A
qxel 5yofohhizp9
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next